Is treatment really reducing infections?
At least one in six patients maintains a viral load over one hundred thousand
Once-daily raltegravir found inferior to twice-daily dosing
Is HIV drug resistance spreading? Early warning signals say 'yes'
Telaprevir works well for people with HIV/HCV co-infection
Does immune reconstitution contribute to ART-related bone loss?
New data from PrEP study shed light on adherence, bone mineral loss and resistance
Abacavir not linked to increased risk of heart attack, reports US FDA
Decreased limb muscle and increased abdominal fat linked to higher mortality in people with HIV
